Healthy Aging Health Center
Walking Boosts Brainpower
Sept. 2, 2008 -- Older adults who take a brisk stroll just three times a week could boost their brainpower and reduce the risk of memory-robbing illnesses such as Alzheimer's disease.
Research published in this week's issue of The Journal of the American Medical Association is believed to be the first to show that home-based exercise improves cognitive function in adults with mild cognitive impairment (MCI), a stage between normal aging and dementia. MCI is marked by mild forgetfulness, language difficulties, and other cognitive problems that are noticeable but do not interfere with everyday tasks.
Nicola T. Lautenschlager, MD, of the University of Melbourne, Australia, and colleagues wanted to see if physical activity would reduce the rate of cognitive decline among older adults at risk for dementia. Their study involved 138 adults aged 50 and older with self-reported memory problems but who did not meet criteria for dementia. The average age was 69 years old.
Researchers randomly assigned study participants to education and usual care or a 24-week home-based exercise program. The team encouraged those in the exercise group to get at least 150 minutes of moderate intensity activity each week, broken down into three, 50-minute sessions. Walking was the most frequently recommended type of activity.
Walking and Brainpower
Those assigned to the activity program exercised 142 more minutes each week, or 20 more minutes per day, than those in the usual care group. "At 6 months, participants in the physical activity group were walking about 9,000 steps a week more than the usual care group," the team writes in the journal article.
Those in the exercise group scored higher on cognitive tests and had better delayed recall. For example, they could more accurately remember a list of words after a certain amount of time had passed than those in the other group.
Researchers also noted lower Clinical Dementia Rating scores among those who were more physically active.
Lautenschlager says the benefits could be seen after 6 months and that they lasted for at least a year after the program's end.
"Unlike medication, which was found to have no significant effect on mild cognitive impairment at 36 months, physical activity has the advantage of health benefits that are not confined to cognitive function alone, as suggested by findings on depression, quality of life, falls, cardiovascular function, and disability," the authors say in a news release.
Alzheimer's disease is an incurable brain disease that robs a person of the mental abilities that affect memory and learning. It is the sixth-leading cause of death in the United States. According to the Alzheimer's Association, about 5 million people in the United States live with the condition. However, the number is expected to substantially increase in the coming decades as America's baby boomers reach their golden years. Study authors say delaying the onset of illness by one year would dramatically reduce the number of cases seen around the world.
del.icio.us
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRIPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.
